In MDS, elevated serum IGF-I levels and IGF-IR expression in CD34+ progenitor cells have been reported, suggesting a role in abnormal hematopoietic stem cell survival and clonal evolution (14). This evidence concerns the gene CD34 and myelodysplastic syndrome.